ask="N/A"
ask_size="N/A"
average_daily_volume="1232110"
bid="N/A"
bid_size="N/A"
book_value="-0.1530"
change="+0.0136"
change_from_200_day_moving_average="-0.0030"
change_from_50_day_moving_average="0.0813"
change_from_52_week_high="-1.1574"
change_From_52_week_low="0.3113"
change_in_percent="+2.7984%"
close="0.4996"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6540"
ebitda="-18.11M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="-0.0900"
eps_estimate_next_year="-0.4500"
ex_dividend_date="N/A"
float_shares="43543000"
high="0.5100"
high_52_weeks="1.6570"
last_trade_date="2/1/2017"
last_trade_price="0.4996"
last_trade_size="404"
last_trade_time="4:02pm"
low="0.4750"
low_52_weeks="0.1883"
market_capitalization="33.83M"
moving_average_200_day="0.5026"
moving_average_50_day="0.4183"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.0000"
open="0.5010"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-0.5929%"
percent_change_from_50_day_moving_average="+19.4435%"
percent_change_from_52_week_high="-69.8491%"
percent_change_from_52_week_low="+165.3213%"
previous_close="0.4860"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="274.2642"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="1.1600"
stock_exchange="ASE"
symbol="BPMX"
volume="772545"
weeks_range_52="0.1883 - 1.6570"
